Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2Parakkal Deepak, Alfred H.J. Kim, Lily E. McMorrow et al.|Annals of Internal Medicine|2021Cited by 321
Glucocorticoids and B Cell Depleting Agents Substantially Impair Immunogenicity of mRNA Vaccines to SARS-CoV-2Parakkal Deepak, Alfred H.J. Kim, Wooseob Kim et al.|medRxiv|2021Cited by 141
Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitorsRita E. Chen, Michael Diamond, Matthew J. Gorman et al.|Med|2021Cited by 36
Reactogenicity of the Messenger <scp>RNA SARS</scp>–<scp>CoV</scp>‐2 Vaccines Associated With Immunogenicity in Patients With Autoimmune and Inflammatory DiseaseMonica Yang, Lianne S. Gensler, Kimberly E. Taylor et al.|Arthritis Care & Research|2022Cited by 8
Reduced antibody activity against SARS-CoV-2 B.1.617.2 Delta virus in serum of mRNA-vaccinated patients receiving TNF-α inhibitorsRita E. Chen, Michael Diamond, Matthew J. Gorman et al.|medRxiv|2021Cited by 2